Home
News & Events
News
122
Results found
-
RSNN Newsletter January 2023
A new edition of the RSNN Newsletter has just been published. -
2022 RSNN Annual Workshop Report available now
The full report of the RSNN Annual Workshop titled "Patient preferences: towards a more structural incorporation in the regulatory pathway" which took place on 5 September 2022 is now available. -
Inaugural lecture Peter Mol
On 25 November Professor and Regulatory Science Network Netherlands co-chair Peter Mol will deliver his inaugural lecture titled: 'Drug Regulatory Science, collaborate to improve drug development and evaluation' at the Academy Building of the University of Groningen. -
RSNN Newsletter September 2022
A new edition of the RSNN Newsletter has just been published. -
FAST and RSNN collaborate to advance and innovate the regulatory system
Both the Centre for Future Affordable and Sustainable Therapy development (FAST) and the Regulatory Science Network Netherlands (RSNN) aim to advance and innovate the regulatory system, to ultimately improve the development, accessibility, and appropriate use of therapies for patients. -
RSNN workshop 2022: presentation files and recording now available
On 5 September the RSNN organized its Annual Workshop. We are looking back at a successful afternoon with great interaction, inspiring speakers and insights from various stakeholder groups (patients, industry, academia, and regulators) on the topic of patient preferences. -
RSNN interview series: Peter Mol
The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. The series also provide an opportunity to highlight some of the current topics in the Regulatory Science field. For this fourth interview in the series, Peter Mol was interviewed. -
Report of RSNN session @ FIGON DMD/EUFEPS 2022 meeting now available
On 2 June 2022 the RSNN hosted a parallel session during the FIGON & EUFEPS European medicines days (www.figondmd.nl) in the Stadsgehoorzaal in Leiden. The session was chaired by Sini Eskola (EFPIA) and speakers from different backgrounds were present. -
Register now for the RSNN Annual workshop 2022
Registration for the RSNN Annual workshop is now open. This year, the workshop will take place on 5 September and focus on the topic "Patient preferences: towards a more structural incorporation in the regulatory pathway". -
RSNN Newsletter May 2022
A new edition of the RSNN Newsletter has just been published. -
RSNN appoints new chairs, welcomes Carla Vos to steering committee
The Regulatory Science Network Netherlands (RSNN) is excited to announce that Marjon Pasmooij (CBG-MEB), Sjaak Bot (Janssen) and Peter Mol (UMCG) have been appointed as new chairs of RSNN. The new chairs each represent one of the three main stakeholder groups within RSNN: regulators, industry and academia. -
2021 RSNN Annual Workshop Report available now
The full report of the RSNN Annual Workshop titled "Upstream regulatory convergence & downstream divergence: unequal access for patients?" which took place on 23 November 2021 is now available. -
Carla Jonker successfully defends PhD thesis on rare disease registries
On 15 February Carla Jonker successfully defended her PhD thesis titled “Rare disease registries: a must for regulatory decision making” at the University Hall in Utrecht. -
EMA launches Regulatory Science research needs initiative in online event
On Tuesday January 18th, the European Medicines Agency (EMA) hosted the Regulatory Science Research Needs (RSRN) launch event. The online event was organized to inform the public and stakeholders, such as researchers and research funders, on the RSRN initiative. -
RSNN workshop 2021: presentation files and recording now available
On 23 November the RSNN organized its Annual Workshop. We are looking back at a successful meeting with great interaction between the participants. The hybrid setting allowed a large audience to attend in person or online. There were many learnings from the various perspectives of the speakers on the topic of upstream convergence and downstream divergence.